摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-amino-2-butoxy-6-hydroxypyrimidine | 1228588-14-4

中文名称
——
中文别名
——
英文名称
4-amino-2-butoxy-6-hydroxypyrimidine
英文别名
6-amino-2-butoxypyrimidin-4-ol;6-Amino-2-butoxypyrimidin-4-ol;4-amino-2-butoxy-1H-pyrimidin-6-one
4-amino-2-butoxy-6-hydroxypyrimidine化学式
CAS
1228588-14-4
化学式
C8H13N3O2
mdl
——
分子量
183.21
InChiKey
BARYMOUWDHRRAX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    76.7
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • METHODS OF PREPARING TOLL-LIKE RECEPTOR MODULATORS
    申请人:Gilead Sciences, Inc.
    公开号:US20160075707A1
    公开(公告)日:2016-03-17
    The present invention provides methods of preparing 4-amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one and related compounds.
    本发明提供了制备4-氨基-2-丁氧基-8-(3-(吡咯烷-1-甲基)苄基)-7,8-二氢蝶啶-6(5H)-酮及相关化合物的方法。
  • METHODS OF PREPARING INTERMEDIATES FOR TOLL-LIKE RECEPTOR MODULATORS
    申请人:Gilead Sciences, Inc.
    公开号:EP3848375A1
    公开(公告)日:2021-07-14
    The present invention provides methods of preparing 4-amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one and related compounds.
    本发明提供了制备4-氨基-2-丁氧基-8-(3-(吡咯烷-1-基甲基)苄基)-7,8-二氢蝶啶-6(5H)-酮及相关化合物的方法。
  • Modulators of toll-like receptors
    申请人:Gilead Sciences, Inc.
    公开号:US10172860B2
    公开(公告)日:2019-01-08
    Provided are modulators of TLRs of Formula II: pharmaceutically acceptable salts thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
    所提供的是式 II 的 TLR 调节剂: 其药学上可接受的盐、含有此类化合物的组合物以及包括施用此类化合物的治疗方法。
  • Identification and Optimization of Pteridinone Toll-like Receptor 7 (TLR7) Agonists for the Oral Treatment of Viral Hepatitis
    作者:Paul A. Roethle、Ryan M. McFadden、Hong Yang、Paul Hrvatin、Hon Hui、Michael Graupe、Brian Gallagher、Jessica Chao、Joseph Hesselgesser、Paul Duatschek、Jim Zheng、Bing Lu、Daniel B. Tumas、Jason Perry、Randall L. Halcomb
    DOI:10.1021/jm400815m
    日期:2013.9.26
    Pteridinone-based Toll-like receptor 7 (TLR7) agonists were identified as potent and selective alternatives to the previously reported adenine-based agonists, leading to the discovery of GS-9620. Analogues were optimized for the immunomodulatory activity and selectivity versus other TLRs, based on differential induction of key cytokines including interferon a (IFN-alpha) and tumor necrosis factor a (TNF-alpha). In addition, physicochemical properties were adjusted to achieve desirable in vivo pharmacokinetic and pharmacodynamic properties. GS-9620 is currently in clinical evaluation for the treatment of chronic hepatitis B (HBV) infection.
  • Intermediates for the preparation of modulators of toll-like receptors
    申请人:GILEAD SCIENCES, INC.
    公开号:EP2818469B1
    公开(公告)日:2017-02-15
查看更多